Dr. Scott D. Boden will succeed Dr. Jay Hess, one of the longest-serving medical school deans in the country.
Read More
CVS Caremark will add Foundayo coverage on June 1 and resume covering Zepbound on Oct. 1.
Read More
The Indianapolis-based drugmaker said some trial participants saw a level of weight loss similar to what patients experience after bariatric surgery.
The Indianapolis drugmaker is purchasing Curevo Inc., LimmaTech Biologics AG and Vaccine Co. Inc. to expand its research and development efforts in infectious disease.
Deal after deal, Eli Lilly and Co. is using the fruits of its success from developing blockbuster GLP-1 medicines to prepare for its next chapter and build a bridge over a looming patent cliff.
Leaders of the technology company Hc1 planned a small conference that used the appeal of the upcoming Indianapolis 500 to bring together health care leaders from around the country for a few days.
At Crispus Attucks High School, students have many career-prep options through the school’s health care pathways program.
The Indianapolis-based company has announced the phased launch of Befrena, a monoclonal antibody injection for treating canine allergic and atopic dermatitis.
The Crossroads Academic Medical Institute, or CAMI, will connect universities, health systems and clinical training sites.
The name BioHeartland was created to give Indiana “a more cohesive and unified way to share the state’s story with investors, companies, researchers and talent around the world,” officials said.
Beta thalassemia major, also known as Cooley’s anemia and transfusion-dependent beta thalassemia, causes the body’s red blood cells to produce less hemoglobin than usual.
The Indianapolis-based drugmaker will work to support UNICEF’s efforts to strengthen primary health care systems to prevent, detect and manage noncommunicable diseases in children and adolescents.
The Indianapolis-based drugmaker is marking 150 years since Col. Eli Lilly founded his company on May 10, 1876.
Corteva, which is planning to split into two publicly traded companies later this year, announced Tuesday that the crop protection part of its business will continue to be based in Indianapolis.
Former Indianapolis Colts quarterback Peyton Manning emceed the event, which took place before about 500 attendees at the new Lilly Event Center in downtown Indianapolis.
Indianapolis-based agricultural giant Corteva, which plans to separate into two independent companies, said it hasn’t yet decided where the companies will be based.
Lilly’s latest commitment at the LEAP District brings the company’s total investment there since 2022 to $18 billion.
In October, Corteva’s board of directors unanimously approved a plan to separate the company’s crop protection business and its seed business into two independent companies.
Lesley Weidenbener and Richard DiMarchi still works a full schedule, researching and teaching at Indiana University.
The serial entrepreneur also launched the affiliated Longevity Today, a website that identifies, processes and summarizes life sciences research and offers information to the public through AI personas.
The Indianapolis-based drugmaker reported profit of $7.4 billion for the first quarter, up from $2.8 billion in the same period a year earlier.
The Indianapolis-based drugmaker will partner with Profluent to develop and commercialize treatments for diseases with severe unmet needs.
